NASDAQHealth CareHealth Information ServicesSnapshot 2026-07-23
Reading OMDA? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
This investment represents a speculative growth opportunity. The company is pursuing aggressive revenue growth targets while facing challenges in cash flow and profitability.
The current valuation suggests that the market has priced in a durable premium compared to peers, indicating high expectations. However, the valuation appears unjustified given the company's ongoing losses and mixed financial performance.
Management aims for 25% revenue growth in 2026, and recent results show progress towards this target. However, cash flow trends are concerning, with negative cash from operations indicating potential challenges ahead.
The thesis hinges on maintaining credibility with guidance and the performance of sector bellwethers. If these companies continue to perform well, OMDA may benefit from the overall healthcare momentum.
In the next 1 to 3 years, OMDA's outlook is shaped by its growth ambitions and sector dynamics, but it faces significant risks. Not investment advice.
The most important moves since the prior daily snapshot.
No, our read on the company is unchanged. There are no new strengths or weaknesses. Recent financial performance remains steady and in the top half of its industry. The market backdrop has shifted, but it does not affect the company's position.
as of 2026-07-23
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Why it matters: The earnings report will provide key updates on revenue, EBITDA, and cash flow. It will shape investor sentiment.
Confirms one read:Earnings report shows revenue and EBITDA growth in line with management's targets.
Confirms the other:The earnings report shows big drops in revenue or EBITDA.
Why it matters: Meeting this growth target shows Omada is on track with its financial goals. It confirms strong demand for its services.
Confirms:Q2 revenue growth of 25% or more compared to Q2 2025.
Disproves:Q2 revenue growth falls below 20% compared to Q2 2025.
Why it matters: Hitting this target shows that Omada makes more money and works better.
Confirms:Adjusted EBITDA reported in the range of $14 million to $20 million.
Disproves:Adjusted EBITDA is less than $7 million for 2026.
Why it matters: Better cash flow is key for Omada's finances. It shows they manage costs well.
Confirms:Cash from operations turns positive in Q2 2026.
Disproves:Cash from operations remains negative in Q2 2026.
Why it matters: More members mean Omada is growing and more people want its services.
Confirms:Total members reported at 1.5 million or more by the end of Q3 2026.
Disproves:Total members reported below 1.3 million by the end of Q3 2026.
